Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.32 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.32 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5899432 | 0.84 | TSHR (0.36) | ENPP2ORAI1ORAI2ORAI3TSHR | |
| SCHEMBL9994954 | 0.83 | CD44 (0.36) | TSHR | |
| SCHEMBL5952272 | 0.81 | ENPP2 (0.32) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL3426496 | 0.81 | ALDH1A1 (0.38) | ENPP2ORAI1ORAI2ORAI3TSHR | |
| SCHEMBL4520012 | 0.81 | ENPP2 (0.32) | ENPP2ORAI1ORAI2ORAI3TSHR | |
| SCHEMBL840950 | 0.81 | ENPP2 (0.32) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL3465794 | 0.79 | ENPP2 (0.56) | ENPP2ORAI1ORAI2ORAI3TSHR | |
| SCHEMBL3521758 | 0.78 | KDM4E (0.34) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL5953116 | 0.78 | ALDH1A1 (0.36) | ENPP2TSHR | |
| SCHEMBL584051 | 0.78 | ALDH1A1 (0.33) | ENPP2ORAI1ORAI2ORAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210070782-A1 | METHOD FOR SYNTHESIZING BORONATE ESTER COMPOUND, SODIUM SALT OF BORONATE ESTER COMPOUND, AND METHOD FOR SYNTHESIZING THE SAME | KOBELCO ECO-SOLUTIONS CO., LTD. (JP) | 2021-03-11 | — | — | US | disclosed |
| EP-3741764-A1 | SYNTHESIS METHOD FOR BORONIC ACID ESTER COMPOUND, AND SODIUM SALT OF BORONIC ACID ESTER COMPOUND AND SYNTHESIS METHOD THEREFOR | Kobelco Eco-Solutions Co., Ltd (JP) | 2020-11-25 | — | — | EP | disclosed |
| CN-111801335-A | Synthesis method of boronic acid ester compound, sodium salt of boronic acid ester compound and synthesis method thereof | 株式会社神钢环境舒立净 | 2020-10-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210070782-A1 | METHOD FOR SYNTHESIZING BORONATE ESTER COMPOUND, SODIUM SALT OF BORONATE ESTER COMPOUND, AND METHOD FOR SYNTHESIZING THE SAME | BRSK1, BRSK2, BRI3BP | ENPP2 3968/4885ORAI1 3430/4885ORAI2 989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.